These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 8922878

  • 1. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH.
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
    Fuhrmann U, Slater EP, Fritzemeier KH.
    Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
    [Abstract] [Full Text] [Related]

  • 3. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
    Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E.
    Ann N Y Acad Sci; 1995 Jun 12; 761():311-35. PubMed ID: 7625729
    [Abstract] [Full Text] [Related]

  • 4. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
    Muhn P, Krattenmacher R, Beier S, Elger W, Schillinger E.
    Contraception; 1995 Feb 12; 51(2):99-110. PubMed ID: 7750297
    [Abstract] [Full Text] [Related]

  • 5. The pharmacological profile of a novel norpregnance progestin (trimegestone).
    Philibert D, Bouchoux F, Degryse M, Lecaque D, Petit F, Gaillard M.
    Gynecol Endocrinol; 1999 Oct 12; 13(5):316-26. PubMed ID: 10599548
    [Abstract] [Full Text] [Related]

  • 6. Nestorone: a progestin with a unique pharmacological profile.
    Kumar N, Koide SS, Tsong Y, Sundaram K.
    Steroids; 2000 Oct 12; 65(10-11):629-36. PubMed ID: 11108869
    [Abstract] [Full Text] [Related]

  • 7. Conception and pharmacodynamic profile of drospirenone.
    Elger W, Beier S, Pollow K, Garfield R, Shi SQ, Hillisch A.
    Steroids; 2003 Nov 12; 68(10-13):891-905. PubMed ID: 14667981
    [Abstract] [Full Text] [Related]

  • 8. Steroid receptor profiling of vinclozolin and its primary metabolites.
    Molina-Molina JM, Hillenweck A, Jouanin I, Zalko D, Cravedi JP, Fernández MF, Pillon A, Nicolas JC, Olea N, Balaguer P.
    Toxicol Appl Pharmacol; 2006 Oct 01; 216(1):44-54. PubMed ID: 16750840
    [Abstract] [Full Text] [Related]

  • 9. In vitro characterization of trimegestone: a new potent and selective progestin.
    Zhang Z, Lundeen SG, Zhu Y, Carver JM, Winneker RC.
    Steroids; 2000 Oct 01; 65(10-11):637-43. PubMed ID: 11108870
    [Abstract] [Full Text] [Related]

  • 10. Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives.
    Schoonen WG, Deckers GH, de Gooijer ME, de Ries R, Kloosterboer HJ.
    J Steroid Biochem Mol Biol; 2000 Nov 15; 74(4):213-22. PubMed ID: 11162927
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of different progestogens: the special case of drospirenone.
    Sitruk-Ware R.
    Climacteric; 2005 Oct 15; 8 Suppl 3():4-12. PubMed ID: 16203650
    [Abstract] [Full Text] [Related]

  • 12. Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins.
    Pollow K, Juchem M, Elger W, Jacobi N, Hoffmann G, Möbus V.
    Contraception; 1992 Dec 15; 46(6):561-74. PubMed ID: 1493716
    [Abstract] [Full Text] [Related]

  • 13. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
    Bergink EW, Hamburger AD, de Jager E, van der Vies J.
    J Steroid Biochem; 1981 Feb 15; 14(2):175-83. PubMed ID: 6451769
    [Abstract] [Full Text] [Related]

  • 14. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE, Enríquez J, García GA, Grillasca I, Pérez-Palacios G.
    J Steroid Biochem Mol Biol; 1997 Jan 15; 60(1-2):121-9. PubMed ID: 9182866
    [Abstract] [Full Text] [Related]

  • 15. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells.
    Jung-Testas I, Renoir M, Bugnard H, Greene GL, Baulieu EE.
    J Steroid Biochem Mol Biol; 1992 Mar 15; 41(3-8):621-31. PubMed ID: 1562533
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
    Cabeza M, Bratoeff E, Gómez G, Heuze I, Rojas A, Ochoa M, Palomino MA, Revilla C.
    J Steroid Biochem Mol Biol; 2008 Sep 15; 111(3-5):232-9. PubMed ID: 18625316
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities.
    Attardi BJ, Page ST, Hild SA, Coss CC, Matsumoto AM.
    J Steroid Biochem Mol Biol; 2010 Feb 15; 118(3):151-61. PubMed ID: 19941958
    [Abstract] [Full Text] [Related]

  • 18. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.
    Krattenmacher R.
    Contraception; 2000 Jul 15; 62(1):29-38. PubMed ID: 11024226
    [Abstract] [Full Text] [Related]

  • 19. Danazol binding to steroid receptors in human uterine endometrium.
    Tamaya T, Wada K, Fujimoto J, Yamada T, Okada H.
    Fertil Steril; 1984 May 15; 41(5):732-5. PubMed ID: 6714450
    [Abstract] [Full Text] [Related]

  • 20. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A, Hahn DW, McGuire JL.
    Am J Obstet Gynecol; 1992 Oct 15; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.